Skip to main content
HQHTekla Healthcare InvestorsHold5.4·$21.39+1.71%
HQH · Why this verdict

Why Tekla Healthcare Investors (HQH) is rated HOLD

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictHOLD
Overall score5.4/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

Despite an attractive valuation with a stated 71% margin of safety and volume accumulation signals, severe revenue deterioration of 42% year-over-year and a Piotroski F-Score of 2 out of 9 raise significant value-trap concerns; with price sitting less than 0.5% below near-term resistance and an unfavorable risk/reward of roughly 0.09-to-1, the setup offers no compelling entry.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

The fund trades at a valuation that screens attractively with a stated 71% margin of safety, yet revenue has declined 42% year-over-year and operating margin has compressed severely, raising the risk that cheapness reflects fundamental deterioration rather than genuine undervaluation.

Stable
Bull case
Expectation
Revenue decline stabilizes above -10% year-over-year over the next two reported periods, signaling that the discount is not a symptom of structural impairment.

CounterDeclining revenue and severe margin compression suggest the assets generating the fund's income are eroding; the discount may widen further as earnings capacity shrinks, making the apparent margin of safety illusory.

A Piotroski F-Score of 2 out of 9 reflects widespread deterioration across profitability, leverage, and operating-efficiency dimensions, signaling that the underlying financial health does not support a value recovery thesis.

Stable
Quality breakdown
Expectation
Piotroski F-Score improves to at least 5 out of 9 on the next annual financial assessment, driven by recovering profitability and improved asset turnover.

CounterWith the F-Score near the floor of the scale, the fund may continue to deteriorate across multiple dimensions before any reversal materializes, and a low score can persist for several reporting periods before improving.

Rising on-balance volume and a price above the 200-day moving average indicate that buyers are absorbing supply at current levels, providing a near-term technical floor despite weak underlying fundamentals.

Stable
Momentum breakdown
Expectation
On-balance volume continues to trend upward and price holds above the 200-day moving average over the next 60 days, confirming sustained accumulation.

CounterTechnical accumulation can be fragile when it coexists with fundamental deterioration; a sentiment shift could rapidly push the price below the 200-day average, eliminating this support.

With price sitting less than 0.5% below near-term resistance and a risk/reward of roughly 0.09-to-1 in your favor, the setup offers essentially no room to appreciate before hitting the technical ceiling, making the current entry point unattractive regardless of longer-term views.

Stable
Gates warning
Expectation
A favorable entry would require the resistance ceiling to be meaningfully revised upward, restoring at least 5% headroom above current levels before re-engagement becomes sensible.

CounterThe fund could consolidate at current levels and eventually break through resistance, particularly if broader market conditions shift and lift the category; the low-upside warning may prove temporary.

Per-dimension breakdown

Value

10.0/10data confidence 20%
ComponentSub-score
P/E10.0
  • Attractively valued

Quality

5.1/10data confidence 86%
ComponentSub-score
ROE8.1
ROA0.0
Gross margin10.0
Current ratio4.1
Moat6.2
Piotroski F2.2
  • Weak Piotroski F-Score: 2/9

Growth

0.0/10data confidence 33%
ComponentSub-score
Rev growth0.0
  • Declining revenue: -42%

Momentum

6.7/10data confidence 100%
ComponentSub-score
RSI3.9
MACD10.0
OBV10.0
MA position9.0
Volume0.6
  • Overbought (RSI 81)
  • Volume accumulation (rising OBV)
  • Above 200-day MA

Sentiment

5.0/10data confidence 33%
ComponentSub-score
Analyst rating5.0

Insider

5.0/10data confidence 50%

Peer rank

6.1/10data confidence 80%
ComponentSub-score
value rank9.5
quality rank9.5
growth rank0.2
  • Attractive P/E vs peers
  • Superior ROE vs peers

Technical

3.4/10data confidence 100%
ComponentSub-score
bollinger0.0
support resistance0.2
52w position9.9

Risk (lower is worse)

8.6/10data confidence 60%
ComponentSub-score
days to cover10.0
volatility7.4
beta8.5

Catalyst

5.5/10data confidence 25%
ComponentSub-score
dividend safety5.5
  • Dividend: 1103.0%

How the verdict was assembled

Engine trigger

Mixed signals. Hold existing position.

Engine technical detail
verdict_path: L4:PATH_F_HOLD_DEFAULT
Passed (7)
  • MOMENTUM:6.7>=5.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:NO_DATE
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)

none

Warning (1)
  • ASYMMETRY:UPSIDE_EXHAUSTED (upside=0.0%)
Reward-to-Risk
0.00
Upside
+0.0%
Downside
12.8%
Sizing output
AVOID

SetupUNKNOWN No clear chart pattern; technical signals are mixed

EdgeNO_EDGE No clear edge identified

SuitabilityAGGRESSIVE MCap $1.2B<$5B

Investment implication

The default F-path HOLD fired without any positive-conviction gate triggering — no momentum acceleration, no quality+value crossover, no setup recognition. Highest-clear gate: MOMENTUM:6.7>=5.5. Top dim: Value at 10.0; weakest: Growth at 0.0. The engine's read is one of pattern absence — no directional conviction in either direction at current asymmetry.

The strongest dimensions are Value at 10.0, Risk (lower is worse) at 8.6, and Momentum at 6.7; the weakest are Growth at 0.0, Technical at 3.4, and Insider at 5.0. The V9 engine cleared all gates with 1 warning, producing an asymmetric reward-to-risk of 0.00 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1The fund trades at a valuation that screens attractively with a stated 71% margin of safety, yet revenue has declined 42% year-over-year and operating margin has compressed severely, raising the risk that cheapness reflects fundamental deterioration rather than genuine undervaluation.

    Trip ifRevenue growth recovers above -10% YoY for 2 consecutive reported periods, demonstrating the decline is stabilizing.

  • P2A Piotroski F-Score of 2 out of 9 reflects widespread deterioration across profitability, leverage, and operating-efficiency dimensions, signaling that the underlying financial health does not support a value recovery thesis.

    Trip ifPiotroski F-Score rises above 5 out of 9 on the next annual financial assessment.

  • P3Rising on-balance volume and a price above the 200-day moving average indicate that buyers are absorbing supply at current levels, providing a near-term technical floor despite weak underlying fundamentals.

    Trip ifOn-balance volume turns negative (falling) for 4 consecutive weeks AND price closes below the 200-day moving average.

  • P4With price sitting less than 0.5% below near-term resistance and a risk/reward of roughly 0.09-to-1 in your favor, the setup offers essentially no room to appreciate before hitting the technical ceiling, making the current entry point unattractive regardless of longer-term views.

    Trip ifPrice breaks above $19.60 resistance and holds above that level for 5 consecutive trading sessions.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks HQH Why this verdict